Mbf 20logo 20offset
Logo 20abbreviated

MBF Therapeutics

Developing innovative turbo-charged cancer vaccines for Man's Best Friends.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Ambler, PA, US
  • Currency USD
  • Founded June 2008
  • Employees 3
  • Incorporation Type C-corp
  • Website mbftherapeutics.com

Company Summary

MBFT is a clinical-stage animal health company developing and commercializing innovative checkpoint inhibitor immunotherapeutic vaccines for treatment and prevention of cancer in companion animals and prevention of infectious diseases in companion animals and livestock. Check-point inhibitors are the ‘hottest’ field in immunotherapy today. This platform technology will generate multiple innovative vaccines for global markets worth >$5B.


  • Founder & VP Marketing and Communications @ RheoGene
    Co-founder Immunotope
    Portfolio Manager, Biostrategy Partners
    Rohm and Haas Co.

  • D2987a45 e675 43c4 995f a2a7b1fb7c8b
    Regulatory and Clinical Development

    20 years experience in animal health development


  • Default avatar
    Hildegund Ertl, Ph.D.